Summary of PCR array results from human prostate xenografts at 200-days post-implantation.

Three different treatment conditions are compared to control xenografts with groups labeled as initial and secondary treatment. Shown are the gene abbreviation, fold change values (+/−), p-value significance, and full gene name (ID). Analysis was performed with linear modeling. Gestational age of human fetal prostate prior to implantation was between 16–21.5 weeks gestation. Sample size (n) for each group is as follows: control/control (4), estrogen/control (4), control/estrogen (2), and estrogen/estrogen (4).
Summary of PCR array results from human prostate xenografts at 200-days post-implantation.